RAFT Pharmaceuticals

biologics to treat chronic pain, neuroinflammation ... and beyond


RAFT is finalist of MilliporeSigma Biotech Grant Program

 April 18, 2019. Raft Pharmaceuticals has been selected as one of the Finalist for 2019 MilliporeSigma Advance Biotech Grant Program! Winners will be announced on May 16 at Biotech Start-up Summit: "Advancing Molecules to Market-Is Yours Next?" https://lnkd.in/ge53D89